Translation of COPE for Publicly-Funded Home Care Clients and their Families

为公共资助的家庭护理客户及其家人提供 COPE 翻译

基本信息

项目摘要

DESCRIPTION (provided by applicant): Dementia, a devastating neurodegenerative disease, is the single biggest cause of disease burden, exacting a substantial health-related toll on individuals with dementia and their families and disproportionately higher health and social service costs. In the absence of a cure or widely effective pharmacotherapy to combat dementia and its health-related consequences, translation and implementation of efficacious non- pharmacologic interventions into existing service programs are sorely needed to improve health-related outcomes for individuals with dementia and their family caregivers (CGs), thereby helping avoid or delay costly hospitalizations and nursing home admissions. Accordingly, in response to PA-11-123, a translational study is proposed in which an evidence-based intervention, Care of Persons with Dementia in their Environments (COPE), is incorporated into the Connecticut Home Care Program for Elders (CHCPE), a combined Medicaid waiver and state revenue-funded home care program for older adults at high risk for nursing home admission. COPE is a 4-month, in-home, non-pharmacologic intervention using occupational therapists and advanced practice nurses to maximize physical function in older adults with dementia and improve dementia management skills of CGs. CHCPE clients with dementia and their CGs (n=290 dyads) will be randomly assigned to receive COPE plus customary CHCPE services, or customary CHCPE services alone. Study outcome measures will be similar to those of the original COPE efficacy trial. A cost-benefit analysis will be conducted to determine the potential economic benefit of adding COPE to customary CHCPE services, and implementation processes will be carefully studied. A Translational Advisory Committee composed of Aging Network and other leaders will help develop and guide national COPE dissemination plans. Study aims for CHCPE clients: Aim 1.1: Determine COPE effect on functional dependence 4 months after randomization (at 4 months). Aim 1.2: Determine COPE effects on engagement in activities, quality of life, and neuropsychiatric symptoms (NPS), at 4 months. Aim 1.3: Determine COPE effects on functional dependence, engagement in activities, quality of life, and NPS, at 12 months. Study aims for CGs: Aim 2.1: Determine COPE effect on perceived CG well-being at 4 months. Aim 2.2: Determine COPE effects on confidence in using dementia management strategies at 4 months. Aim 2.3: Determine COPE effects on CG perceived well-being, confidence in using activities, and ability to keep client at home, at 12 months. Translational study aims: Aim 3.1: Determine the net financial benefit of COPE, accounting for COPE intervention costs, CHCPE usual care costs, nursing home costs, and other service costs, at 4 and 12 months. Aim 3.2: Determine the feasibility and acceptability of COPE implementation into the CHCPE from multiple stakeholder viewpoints. This translational study will serve as a national model for embedding and evaluating evidence-based services in publicly-funded home care programs for older adults with dementia at risk for nursing home admission.
描述(由申请人提供):痴呆症是一种毁灭性的神经退行性疾病,是疾病负担的最大单一原因,对痴呆症患者及其家庭造成了大量与健康相关的费用,并且不成比例地增加了健康和社会服务费用。在缺乏治愈或广泛有效的药物疗法来对抗痴呆及其健康相关后果的情况下,迫切需要将有效的非药物干预措施转化和实施到现有的服务计划中,以改善患有痴呆的个体及其家庭照顾者(CG)的健康相关结果,从而帮助避免或延迟昂贵的住院和疗养院入院。因此,为了响应PA-11 - 123,提出了一项转化研究,其中将循证干预措施,痴呆症患者在其环境中的护理(COPE)纳入康涅狄格州老年人家庭护理计划(CHCPE),这是一项针对养老院入院风险高的老年人的医疗补助豁免和州收入资助的家庭护理计划。COPE是一种为期4个月的家庭非药物干预,使用职业治疗师和高级实践护士,以最大限度地提高老年痴呆症患者的身体功能,并提高CG的痴呆症管理技能。患有痴呆症的CHCPE客户及其CG(n = 290对)将被随机分配接受COPE加常规CHCPE服务,或仅接受常规CHCPE服务。研究结局指标将与原始COPE疗效试验相似。将进行成本效益分析,以确定将COPE添加到常规CHCPE服务中的潜在经济效益,并将仔细研究实施过程。由老龄网络和其他领导人组成的翻译咨询委员会将帮助制定和指导国家COPE传播计划。CHCPE客户的研究目的:目的1.1:确定随机化后4个月(4个月)COPE对功能依赖的影响。目的1.2:在4个月时确定COPE对活动参与、生活质量和神经精神症状的影响。目的1.3:确定COPE对12个月时的功能依赖性、活动参与度、生活质量和生活质量的影响。CG的研究目标:目标2.1:确定COPE对4个月时感知CG幸福感的影响。目的2.2:确定COPE对4个月时使用痴呆症管理策略的信心的影响。目标2.3:确定COPE对12个月时CG感知幸福感、使用活动的信心和让客户留在家中的能力的影响。翻译研究的目的:目标3.1:确定COPE的净经济效益,占COPE干预成本,CHCPE通常的护理成本,疗养院的成本,和其他服务成本,在4个月和12个月。目标3.2:从多个利益攸关方的角度,确定将COPE纳入CHCPE的可行性和可接受性。这项转化研究将作为一个国家模式,用于在公共资助的家庭护理计划中嵌入和评估循证服务,为有老年痴呆症风险的老年人提供养老院入院。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard H Fortinsky其他文献

Real-World Insights Into Dementia Diagnosis Trajectory and Clinical Practice Patterns Unveiled by Natural Language Processing: Development and Usability Study
通过自然语言处理揭示的痴呆症诊断轨迹和临床实践模式的真实世界见解:开发和可用性研究
  • DOI:
    10.2196/65221
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    4.800
  • 作者:
    Hunki Paek;Richard H Fortinsky;Kyeryoung Lee;Liang-Chin Huang;Yazeed S Maghaydah;George A Kuchel;Xiaoyan Wang
  • 通讯作者:
    Xiaoyan Wang

Richard H Fortinsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard H Fortinsky', 18)}}的其他基金

Data Core RC2
数据核心 RC2
  • 批准号:
    10294031
  • 财政年份:
    2021
  • 资助金额:
    $ 59.02万
  • 项目类别:
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)
  • 批准号:
    10294028
  • 财政年份:
    2021
  • 资助金额:
    $ 59.02万
  • 项目类别:
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)
  • 批准号:
    10668310
  • 财政年份:
    2021
  • 资助金额:
    $ 59.02万
  • 项目类别:
Data Core RC2
数据核心 RC2
  • 批准号:
    10668322
  • 财政年份:
    2021
  • 资助金额:
    $ 59.02万
  • 项目类别:
Impact of AD/ADRD on Health-Related Outcomes in a Statewide Population Enrolled in a Publicly-Funded HCBS Waiver Program for Older Adults
AD/ADRD 对参加公共资助的老年人 HCBS 豁免计划的全州人口健康相关结果的影响
  • 批准号:
    10095054
  • 财政年份:
    2020
  • 资助金额:
    $ 59.02万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    9105676
  • 财政年份:
    2014
  • 资助金额:
    $ 59.02万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    8696260
  • 财政年份:
    2014
  • 资助金额:
    $ 59.02万
  • 项目类别:
Proactive Primary Dementia Care
积极主动的原发性痴呆护理
  • 批准号:
    7897932
  • 财政年份:
    2009
  • 资助金额:
    $ 59.02万
  • 项目类别:
RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE
医疗保险家庭护理中的资源使用和患者结果
  • 批准号:
    6040884
  • 财政年份:
    1999
  • 资助金额:
    $ 59.02万
  • 项目类别:
RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE
医疗保险家庭护理中的资源使用和患者结果
  • 批准号:
    6187610
  • 财政年份:
    1999
  • 资助金额:
    $ 59.02万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.02万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了